Skip to content
GLP-1 Decoder

VK2735: Status, Trials and Expected Price

Vk2735: where it is in development, what the trials show so far, and when it could reach patients.

VK2735 at a glance

Weight loss in its main trial
VK273514.7%

Weight loss as a percent of body weight after 13 weekly doses (Phase 2 VENTURE).

Sources: ir.vikingtherapeutics.com.